Accéder au contenu principal

hfpef-diva

Teams

Inserm UMR1096 – Rouen University, FR – Ebba Brakenhielm

Research performed in the Inserm U1096 Unit at UniRouen Normandy, concerns evaluation of the mechanisms behind and novel treatments of cardiovascular diseases, focusing on vascular protection and improvement of cardiac contractile function. This research is transversal, and performed both in experimental models and in human.

The DIVA team, led by Dr Ebba Brakenhielm, includes:

4 PhD students: Theo Lemarcis, Chloe Valentin and Océane Laguerre, and Emilie Pecetto

1 Lab technician: Benjamin Thomas

The CARDINNOV team in Rouen received national funding from the ANR (Agence National de la Recherche)

Cardiovascular Research Institute Maastricht (CARIM) - Maastricht University, NL – Vanessa van Empel

CARIM is one of the eight research institutes of the Faculty of Health, Medicine and Life Sciences (FHML) of Maastricht University and is embedded within the Maastricht University Medical Center+ (Maastricht UMC+). CARIM collaborates closely with the Heart+Vascular Center of Maastricht UMC+.

The DIVA team led by Dr Vanessa van Empel includes:

2 postdocs:  Dr Xinyu LI and Dr Jerremy Weerts

1 PhD student: Eline Verghote

The CARDINNOV team in Maastricht received national funding from the Dutch NWO (Nederlandse Onrganisatie voor Wetenschappelijk Onderzoek).

Centro de Investigación Médica Aplicada (CIMA) – Navarra University, ES – Arantxa González Miqueo

Cima's research is multidisciplinary, carried out by teams of professionals from various fields (biologists, biochemists, pharmacists, engineers, physicians, laboratory technicians, etc.). In collaboration with the Clinic, synergies are favored with other professionals from other centers of the biomedical and technological campus of the University of Navarra, as well as with professionals from the Navarra Hospital Complex and Navarrabiomed, within the framework of the Navarra Health Research Institute (Idisna).

Since 2018, Cima has the status of University Research Institute of the Universidad de Navarra.

The team led by Pr Arantxa González-Miqueo includes:

Begoña López Phd – Researcher

Susana Ravassa PhD – Researcher

Gorka San José PhD – Researcher CIBERCV

Laura Martinez BSc – Technician

Leire Tapia -  PhD student

The CARDINNOV team in Pamplona received national funding from the ISCiii (Instituto de Salud Carlos III)

Center for Molecular and Vascular Biology- KU Leuven, BE – Elizabeth Jones

Research in the Department of Cardiovascular Sciences at KU Leuven, includes exploratory basic research, clinical and population studies, and diagnostic and technological innovation.

The group of Pr Elizabet Jones is focused on vascular cell biology to understand how blood flow dynamics change endothelial cell behaviour and gene expression. The two main diseases studied in the Jones group are arterial-venous malformations and diastolic heart failure.  In diastolic heart failure, the presence of metabolic diseases such as hypertension and diabetes lead to inappropriate pruning of vessels such that capillary rarefaction occurs.

The DIVA team currently includes:

  • Ellaline Cami,  PhD student

The CARDINNOV team in Maastricht received national funding from the Belgian FWO (Research Foundation - Flanders).

Hybrigenics SAS, Évry-Courcouronnes, FR – Jean-Christophe Rain

With our innovative technologies and team of experts, Hybrigenics are supporting the scientific community to achieve their goals, advance their knowledge about protein interactions and make new discoveries.
Hybrigenics specialises in high-throughput technologies including Y2H-based screens, and the development and validation of single-chain antibodies (nanobodies/hybribody).

The DIVA team, led by Dr Jean-Christophe Rain, includes:

  • Dr Stéphanie Blachon, project manager (orcid: 0000-0002-0092-9851)

The CARDINNOV team at Hybrigenics received national funding from the ANR (Agence National de la Recherche).

Healthy Heart Fund – Leuven, BE – Krista Bogaert

Healthy Heart Fund (HHF) is a Belgian charity associated with the Department of Cardiovascular Sciences at KU Leuven (the university) and UZ Leuven (the hospital).  In the DIVA Project, HHF through Krista Bogaert is a Collaborator . In particular, the HHF will assist this research consortium in their quest for direct communication with patients so as to ensure open exchanges of the potential impact and relevance of their work for cardiovascular disease patients in Belgium.